First- and second-line anti-tuberculosis drug resistance in Northwest Ethiopia

International Journal of Tuberculosis and Lung Disease

Volumn 16, Issue 6, 2012, Pages 805-811

  Tessema, Belay ^a,b   Beer, J ^b   Emmrich, F ^b,c   Sack, U ^b,c   Rodloff, A C ^b  

^a UNIVERSITY OF GONDAR   (Ethiopia)

^b UNIVERSITY HOSPITAL LEIPZIG   (Germany)

^c FRAUNHOFER INSTITUTE FOR CELL THERAPY AND IMMUNOLOGY   (Germany)

Author keywords

Drug resistance; First line anti tuberculosis drugs; Second line anti tuberculosis drugs; Tuberculosis

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; CAPREOMYCIN; CYCLOPEPTIDE; ETHAMBUTOL; ISONIAZID; KANAMYCIN; MOXIFLOXACIN; OFLOXACIN; PYRAZINAMIDE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; STREPTOMYCIN; TUBERCULOSTATIC AGENT; VIOMYCIN;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CHILD; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; ETHIOPIA; FEMALE; HIV TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANT TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; RISK ASSESSMENT; SCHOOL CHILD; SPUTUM SMEAR; TUBERCULOSIS; TUBERCULOSIS CONTROL;

ADOLESCENT; ADULT; AGED; ANTITUBERCULAR AGENTS; CHI-SQUARE DISTRIBUTION; CHILD; CROSS-SECTIONAL STUDIES; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ETHIOPIA; FEMALE; HOSPITALS; HUMANS; LOGISTIC MODELS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYCOBACTERIUM TUBERCULOSIS; RISK ASSESSMENT; RISK FACTORS; SPUTUM; TIME FACTORS; TREATMENT FAILURE; TUBERCULOSIS, MULTIDRUG-RESISTANT; TUBERCULOSIS, PULMONARY; YOUNG ADULT;

EID: 84861147752     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: 10.5588/ijtld.11.0522     Document Type: Article

References (37)

1. World Health Organization. Anti-tuberculosis drug resistance in the world. 4th global report. WHO/HTM/TB/2008.394. Geneva, Switzerland: WHO, 2008.
2. Caws M, Thwaites G, Dunstan S, et al. The influence of host and bacterial genotype on the development of disseminated disease with Mycobacterium tuberculosis. Plos Pathol 2008; 4: 1-9.
3. Federal Ministry of Health, Government of Ethiopia. Guideline for programme and clinical management of drug-resistant tuberculosis. 1st ed. Addis Ababa, Ethiopia: FMOH, 2009.
4. Central Statistical Authority, 2007. Summary and statistical report of the 2007 population and housing census, population size by age and sex, Addis Ababa, Ethiopia: CSA, 2008.
5. World Health Organization. Multidrug and extensively drug-resistant TB (M/XDR-TB): 2010 global report on surveillance and response. WHO/HTM/TB/2010.3. Geneva, Switzerland: WHO, 2010.
6. World Health Organization. Global tuberculosis control. Surveillance, planning and financing. WHO report. WHO/HTM/TB/2008.393. Geneva, Switzerland: WHO, 2008.
7. Ministry of Health of Ethiopia. Tuberculosis, Leprosy and TB/HIV Prevention and Control Programme manual. Addis Ababa, Ethiopia: MOH, 2008.
8. Marcos A E. The global situation of MDR-TB. Tubercle 2003; 83: 44-51.
9. Tessema B, Beer J, Emmrich F, Sack U, Rodloff A C. Rate of recovery of Mycobacterium tuberculosis from frozen acid-fastbacillus smear-positive sputum samples subjected to long term storage in Northwest Ethiopia. J Clin Microbiol 2011; 49: 2557-2561.
10. Deutsches Institut für Normung. Medical microbiology: diagnosis of tuberculosis. Part 3: detection of mycobacteria by culture methods. Berlin, Germany: Beuth Verlag, 1986.
11. Beer J, Küchler R, Rodloff A C. Investigations about the possibility for testing the susceptibility of mycobacteria with the MB/BacT culture system. J Lab Med 1997; 21: 390-398. (Pubitemid 27390429)
12. Tortoli E, Mattei R, Savarino A, Bartolini L, Beer J. Comparison of Mycobacterium tuberculosis susceptibility testing performed with BACTEC 460 TB (Becton Dickinson) and MB/BacT (Organon Teknika) systems. Diagnostic Microbio Infec Dis 2000; 38: 83-86.
13. Dosso M, Bonard D, Msellati P, et al. Primary resistance to antituberculosis drugs: a national survey conducted in Côte d'Ivoire in 1995-1996. Int J Tuberc Lung Dis 1999; 3: 805-809. (Pubitemid 29425951)
14. Garin B, Di Costanzo B, Kassa Kelembho E, et al. Drug-resistant Mycobacterium tuberculosis strains in tuberculosis in patients in Bangui, Central African Republic. AIDS 1995; 9: 213-214.
15. Agonafir M, Lemma E, Wolde-Meskel D, et al. Phenotypic and genotypic analysis of multidrug-resistant tuberculosis in Ethiopia. Int J Tuberc Lung Dis 2010; 14: 1259-1265.
16. Bercion R, Kuaban C. Initial resistance to antituberculosis drugs in Yaounde, Cameroon in 1995. Int J Tuberc Lung Dis 1997; 1: 110-114. (Pubitemid 127509665)
17. van der Werf T S, Groothuis D G, van Klingeren B. High initial resistance in pulmonary tuberculosis in Ghana. Tubercle 1989; 70: 249-255. (Pubitemid 20001745)
18. Idigbe E O, Duque J P, John E K, Annam O. Resistance to anti-tuberculosis drugs in treated patients in Lagos, Nigeria. J Trop Med Hyg 1992; 95: 186-191.
19. Kuaban C, Bercion R, Jifon G, Cunin P, Ngu Blackett K. Acquired anti-tuberculosis drug resistance in Yaounde, Cameroon. Int J Tuberc Lung Dis 2000; 4: 427-432. (Pubitemid 30256845)
20. Abate G. Drug-resistant tuberculosis in Ethiopia: problem scenarios and recommendation. Ethiop Med J 2002; 40: 79-86.
21. Asmamaw D, Seyoum B, Makonnen E, et al. Primary drug resistance in newly diagnosed smear positive tuberculosis patients in Addis Ababa, Ethiopia. Ethiop Med J 2008; 46: 367-374.
22. Gebeyehu M, Lemma E, Eyob G. Prevalence of drug-resistant tuberculosis in Arsi Zone, Ethiopia. Ethiop J Health Dev 2001; 15: 11-16.
23. Bretzel G, Aziz M, Wendl-Richter U, et al. Anti-tuberculosis drug resistance surveillance in Uganda 1996-1997. Int J Tuberc Lung Dis 1999; 3: 810-815. (Pubitemid 29425952)
24. Kuaban C, Bercion R, Noeske J, Cunin P, Nkamsse P, Ngo Niobe S. Anti-tuberculosis drug resistance in the West Province of Cameroon. Int J Tuberc Lung Dis 2000; 4: 356-360. (Pubitemid 30194112)
25. Mac-Arthur A Jr, Gloyd S, Perdigão P, Noya A, Sacarlal J, Kreiss J. Characteristics of drug resistance and HIV among tuberculosis patients in Mozambique. Int J Tuberc Lung Dis 2001; 5: 894-902. (Pubitemid 32976632)
26. World Health Organization. Anti-tuberculosis drug resistance in the world. 2nd report. Prevalence and trends. The WHO/IUATLD Global Project on Anti-tuberculosis Drug Resistance Surveillance. WHO/CDS/TB/2000.278. Geneva, Switzerland: WHO, 2000.
27. World Health Organization. Global tuberculosis control: epidemiology, strategy, financing. WHO report 2009. WHO/HTM/TB/2009.411. Geneva, Switzerland: WHO, 2010.
28. Faustini A, Hall A J, Perucci C A. Risk factors for multidrugresistant tuberculosis in Europe: a systematic review. Thorax 2006; 61: 158-163. (Pubitemid 43235434)
29. Granich R M, Oh P, Lewis B, Porco T C, Flood J. Multidrug resistance among persons with tuberculosis in California, 1994-2003. J Am Med Assoc 2005; 293: 2732-2739. (Pubitemid 40965085)
30. Min S M, Kelly P, Byrne C, Clancy L. Antibiotic resistant tuberculosis and bovine tuberculosis in an Irish hospital population (1991 to 2001). Ir Med J 2005; 98: 38-40. (Pubitemid 40852022)
31. Surucuoglu S, Ozkutuk N, Celik P, et al. Drug-resistant pulmonary tuberculosis in western Turkey: prevalence, clinical characteristics and treatment outcome. Ann Saud Medici 2005; 25: 313-318. (Pubitemid 41288669)
32. Raviglione M C, Gupta R, Dye C M, Espinal M A. The burden of drug-resistant tuberculosis and mechanisms for its control. Ann NewYork Acad Sci 2001; 953: 88-97. (Pubitemid 34072980)
33. Demissie M, Gebeyehu M, Berhane Y. Primary resistance to anti-tuberculosis drugs in Addis Ababa, Ethiopia. Int J Tuberc Lung Dis 1997; 1: 64-67. (Pubitemid 127509688)
34. Mulenga C, Chonde A, Bwalya I C, et al. Low occurrence of tuberculosis drug resistance among pulmonary tuberculosis patients from an urban setting, with a long-running DOTS program in Zambia. Tuberc Res Treat 2010; (938178): 1-6.
35. Umubyeyi A, Rigouts L, Shamputa I C, Dediste A, Struelens M, Portaels F. Low levels of second-line drug resistance among multidrug-resistant Mycobacterium tuberculosis isolates from Rwanda. Int J Infect Dis 2008; 12: 152-156. (Pubitemid 351249172)
36. Ministry of Health. Single-point HIV prevalence estimate. Addis Ababa, Ethiopia: MOH, 2007. http://www.etharc.org/amhara/Asset/Dowloadables/ singlepointprev-2007.pdf Accessed January 2012.
37. Kassu A, Mengistu G, Ayele B. Co-infection and clinical manifestation of TB in HIV infected and uninfected adults at teaching hospital, Northwest Ethiopia. J Microbiol Immunol Infect 2007; 40: 116-122. (Pubitemid 46999318)